Literature DB >> 28894502

Use of smoking cessation products: A survey of patients in community pharmacies.

Alan Phung1, Lauren Luo1, Noor Breik1, Silvia Alessi-Severini1.   

Abstract

OBJECTIVES: At 17.3%, smoking rates in Manitoba continue to exceed the national average. In this province, a total health care spending of more than $200 million per year has been attributed to smoking. This study examined the use of smoking cessation agents, including nicotine replacement products and prescription medications, in a sample of smokers in the city of Winnipeg.
METHODS: A simple multiple-choice questionnaire was administered to willing individuals attending 2 community pharmacies in Winnipeg, Manitoba. Data on demographics, smoking habits, previous attempts of smoking cessation and previous and current use of over-the-counter and prescription smoking cessation products were collected anonymously.
RESULTS: Of the 2237 individuals who were approached, 586 were smokers (26.2%) and 180 responded to the survey (30.7%); 48.9% were female. A majority of smokers (32.8%) reported smoking 16 to 25 cigarettes per day. More than 90% had smoked for more than 5 years, 27.2% had more than 5 previous quit attempts and 82.1% used smoking cessation products with the intention to quit. Self-motivation (44.4%) and family/friend advice (28.3%) were major reasons for quitting. Impact of health care practitioners' advice was low (6.4%). More than 80% of respondents reported that they had no insurance coverage for their smoking cessation products. Despite having the highest rate of use, both nicotine gum (33.3%) and patches (24.4%) were reported to have lower rates of perceived efficacy. Electronic cigarette (97.9%) and varenicline (70.6%) had the highest rates of reported effectiveness.
CONCLUSION: Smokers wanting to quit undergo many attempts. Pharmacists should assume a key role in reaching out to smokers.

Entities:  

Year:  2017        PMID: 28894502      PMCID: PMC5582676          DOI: 10.1177/1715163517723035

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


  15 in total

1.  Smokers' interest in using nicotine replacement to aid smoking reduction.

Authors:  Saul Shiffman; John R Hughes; Stuart G Ferguson; Janine L Pillitteri; Joseph G Gitchell; Steven L Burton
Journal:  Nicotine Tob Res       Date:  2007-11       Impact factor: 4.244

2.  Meta-analysis of the effectiveness of smoking cessation interventions in community pharmacy.

Authors:  M Saba; J Diep; B Saini; T Dhippayom
Journal:  J Clin Pharm Ther       Date:  2014-01-13       Impact factor: 2.512

3.  Lung function and respiratory symptoms in a randomized smoking cessation trial of electronic cigarettes.

Authors:  Fabio Cibella; Davide Campagna; Pasquale Caponnetto; Maria Domenica Amaradio; Massimo Caruso; Cristina Russo; Donald W Cockcroft; Riccardo Polosa
Journal:  Clin Sci (Lond)       Date:  2016-08-19       Impact factor: 6.124

4.  Characteristics of e-cigarette users and their perceptions of the benefits, harms and risks of e-cigarette use: survey results from a convenience sample in Ottawa, Canada.

Authors:  K D Volesky; A Maki; C Scherf; L M Watson; E Cassol; P J Villeneuve
Journal:  Health Promot Chronic Dis Prev Can       Date:  2016-07       Impact factor: 3.240

5.  Assessing the reach of nicotine replacement therapy as a preventive public health measure.

Authors:  S J Bondy; L M Diemert; J C Victor; P W McDonald; J E Cohen
Journal:  Chronic Dis Inj Can       Date:  2012-12

6.  Use and perceived helpfulness of smoking cessation methods: results from a population survey of recent quitters.

Authors:  Wai Tak Hung; Sally M Dunlop; Donna Perez; Trish Cotter
Journal:  BMC Public Health       Date:  2011-07-27       Impact factor: 3.295

7.  An internet survey of use, opinions and preferences for smoking cessation medications: nicotine, varenicline, and bupropion.

Authors:  Jean-François Etter; Nina G Schneider
Journal:  Nicotine Tob Res       Date:  2012-04-22       Impact factor: 4.244

8.  Smokers' use of nicotine replacement therapy for reasons other than stopping smoking: findings from the ITC Four Country Survey.

Authors:  David Hammond; Jessica L Reid; Pete Driezen; K Michael Cummings; Ron Borland; Geoffrey T Fong; Ann McNeill
Journal:  Addiction       Date:  2008-10       Impact factor: 6.526

9.  Ideal and actual involvement of community pharmacists in health promotion and prevention: a cross-sectional study in Quebec, Canada.

Authors:  Marie-Claude Laliberté; Sylvie Perreault; Nicole Damestoy; Lyne Lalonde
Journal:  BMC Public Health       Date:  2012-03-15       Impact factor: 3.295

Review 10.  Effectiveness of smoking cessation therapies: a systematic review and meta-analysis.

Authors:  Ping Wu; Kumanan Wilson; Popey Dimoulas; Edward J Mills
Journal:  BMC Public Health       Date:  2006-12-11       Impact factor: 3.295

View more
  1 in total

1.  Electronic nicotine devices to aid smoking cessation by alcohol- and drug-dependent clients: protocol for a pilot randomised controlled trial.

Authors:  Ashleigh Guillaumier; Victoria Manning; Olivia Wynne; Coral Gartner; Ron Borland; Amanda L Baker; Catherine J Segan; Eliza Skelton; Lyndell Moore; Ramez Bathish; Dan I Lubman; Billie Bonevski
Journal:  Trials       Date:  2018-08-02       Impact factor: 2.279

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.